BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

BioPorto Diagnostics A/S公司成立于2001年，是丹麥一家專門生產(chǎn)抗體和基于抗體的各種生物產(chǎn)品的公司,，目前公司員工有25人,。公司致力于生產(chǎn)、銷售高質(zhì)量產(chǎn)品,，并提供各種相關服務,。BioPorto擁有Bioporto Diagnostics和Antibody shop兩個品牌，分別側(cè)重于診斷試劑盒和抗體產(chǎn)品,。在30多個國家有代理商,，產(chǎn)品銷售網(wǎng)絡遍布quan球，99%以上為出口銷售,。BioPorto Diagnostics旗下產(chǎn)品主要為幾種臨床快速診斷試劑盒,，包括診斷早期急性腎損傷的NGAL ELISA kit，評估原發(fā)性免疫缺陷的MBL Oligomer ELISA kit,，同時還有相關其他種屬的科研用試劑盒和抗原抗體,。其最新推出的產(chǎn)品有檢測人體血漿中的活性蛋白C-蛋白C抑制物(APC-PCI)復合物的APC-PCI ELISA kit，高純度人IgE單克隆抗體,，以及Glucagon-like peptide-1和Exendin-4相關的單抗,。